VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRLBProto Labs, Inc.
$79.79$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPRLBBalance Sheet

Proto Labs, Inc. (PRLB) Balance Sheet

17Y historyFree accessUpdated daily

The company maintains a pristine capital structure with a 0.00 debt-to-equity ratio and a robust current ratio of 3.51, providing significant insulation against cyclical industrial downturns.

PRLB Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Total Current Assets248.58M233.54M194.85M200.66M186.57M183.49M242M236.42M215.36M165M157.78M138M107.86M109.8M90.16M28.08M18.89M12.16M
Cash & Short-Term Investments136.28M128.12M103.09M102.8M80.13M77.51M161.69M160.66M131.8M94.13M108.27M80.85M74.03M79.38M61.9M8.38M6.85M4.45M
Cash Only123.97M110.83M89.07M83.79M56.56M65.93M127.6M125.22M85.05M36.71M68.8M47.65M43.33M43.04M36.76M8.13M6.1M2.7M
Short-Term Investments12.31M17.3M14.02M19.01M23.57M11.58M34.09M35.44M46.75M57.42M39.48M33.2M30.71M36.34M25.14M250K750K1.75M
Accounts Receivable85.55M81.43M69.41M75.08M80.27M81.37M58.42M57.45M64.91M53.34M34.51M42.15M24.23M18.32M17.67M11.53M8.37M5.47M
Days Sales Outstanding54.8955.7550.5854.3859.9960.8549.0845.7153.1756.5142.2658.2642.194151.1842.5547.0845.57
Inventory14.87M14.4M12.3M13.66M13.58M13.16M10.86M10.07M10.09M11.27M9.31M9.77M6.19M5.17M4.62M3.8M1.61M1.07M
Days Inventory Outstanding17.1217.7616.1717.6818.1618.118.3116.4617.7927.3125.9232.5127.8530.733.8235.2423.0421.02
Other Current Assets11.87M9.59M10.05M9.12M12.6M00000000455K609K932K222K226K
Total Non-Current Assets529.99M526.81M548.66M571.69M615.6M745.09M502.2M437.25M403.62M353.73M256.46M223.03M179.17M120.38M83.77M34.25M19.47M16.63M
Property, Plant & Equipment212.31M215.46M230.95M259.24M279.16M287.82M294.92M275.14M228M166.66M139.47M125.47M91.63M56.1M45.32M34.25M19.47M16.63M
Fixed Asset Turnover2.54x2.47x2.17x1.94x1.75x1.70x1.47x1.67x1.95x2.07x2.14x2.10x2.29x2.91x2.78x2.89x3.33x2.64x
Goodwill273.99M273.99M273.99M273.99M273.99M400.61M128.75M128.75M128.75M129.75M28.92M28.92M28.92M00000
Intangible Assets17.53M18.61M21.42M25.58M31.25M38M14.35M17.37M19.85M17.61M2.65M3.34M4.08M00000
Long-Term Investments53.49M14.31M17.77M8.02M26.42M14.34M59.36M12.96M23.58M37.03M84.48M64.79M54.32M64.02M36.97M000
Other Non-Current Assets26.16M4.44M4.52M4.86M4.78M4.32M4.83M3.03M3.44M2.67M933K517K227K256K285K000
Total Assets778.57M760.36M743.51M772.35M802.17M928.58M744.2M673.67M618.99M517.37M414.24M361.04M287.51M230.18M173.93M62.33M38.35M28.8M
Asset Turnover0.72x0.70x0.67x0.65x0.61x0.53x0.58x0.68x0.72x0.67x0.72x0.73x0.73x0.71x0.72x1.59x1.69x1.52x
Asset Growth %6.28%2.27%-3.73%-3.72%-13.61%24.78%10.47%8.83%19.64%24.9%14.74%25.57%24.91%32.34%179.06%62.5%33.19%-
Total Current Liabilities70.72M67M53.27M49.68M71.58M54.9M50.25M47.58M52.73M42.38M23.43M26.26M18.76M13.66M11.54M9.94M8.46M7.63M
Accounts Payable19.63M15.1M15.5M15.64M17.36M25.36M18.25M16.8M17.41M15.88M11.32M13.64M7.88M6.46M4.76M4.43M2.75M1.53M
Days Payables Outstanding20.5118.6320.3820.2523.2134.8830.7527.4530.7138.4731.5245.3935.4438.3734.8441.1339.5230.15
Short-Term Debt1.24M1.44M00000005M00000390K00
Deferred Revenue (Current)000000000000000000
Other Current Liabilities69.48M26.78M16.55M15.29M12.74M13.7M11.99M15.06M18.13M12.1M7.67M9.99M6.07M6.2M6M4.38M00
Current Ratio3.51x3.49x3.66x4.04x2.61x3.34x4.82x4.97x4.08x3.89x6.74x5.25x5.75x8.04x7.81x2.82x2.23x1.59x
Quick Ratio3.30x3.27x3.43x3.76x2.42x3.10x4.60x4.76x3.89x3.63x6.34x4.88x5.42x7.66x7.41x2.44x2.04x1.45x
Cash Conversion Cycle51.5154.8846.3751.8254.9344.0736.6434.7240.2545.3536.6545.3734.633.3350.1736.6630.5936.44
Total Non-Current Liabilities24.72M22.48M20.09M27.38M32.94M45.19M49.59M40.3M24.75M13.77M10.98M7.13M3.22M4.87M5.69M5.74M65.98M64.2M
Long-Term Debt1.38M1.61M00000000000159K356K613K1.29M4.69M
Capital Lease Obligations4.32M1.61M1.92M3.6M2.25M3.6M9.51M8.56M000010K159K356K613K-62.72M-58.54M
Deferred Tax Liabilities61.32M16.6M13.56M18.74M26.32M35.89M33.85M26.28M20.16M6.97M7M4.24M1.85M3.68M4.55M4.25M1.31M759K
Other Non-Current Liabilities4.39M2.67M4.61M5.03M4.36M5.71M6.24M5.45M4.59M6.8M3.98M2.89M1.36M869K426K258K-62.05M-58.32M
Total Liabilities95.44M89.48M73.36M77.06M104.52M100.09M99.85M87.88M77.49M56.15M34.41M33.39M21.98M18.53M17.23M15.68M74.44M71.83M
Total Debt2.62M4.65M3.52M5.48M21.35M7.44M13.33M11.9M05M00149K363K629K1M5.03M9.3M
Net Debt-121.35M-106.17M-85.56M-78.31M-35.2M-58.48M-114.27M-113.32M-85.05M-31.71M-68.8M-47.65M-43.18M-42.68M-36.13M-7.13M-1.07M6.59M
Debt / Equity0.00x0.01x0.01x0.01x0.03x0.01x0.02x0.02x-0.01x--0.00x0.00x0.00x0.02x--
Debt / EBITDA0.05x0.08x0.06x0.08x0.32x0.11x0.14x0.11x-0.06x--0.00x0.01x0.02x0.03x0.25x0.86x
Net Debt / EBITDA-2.14x-1.77x-1.40x-1.19x-0.53x-0.86x-1.24x-1.02x-0.74x-0.35x-0.87x-0.59x-0.60x-0.72x-0.88x-0.23x-0.05x0.61x
Interest Coverage--124.36x26.41x--------------
Total Equity683.13M670.87M670.15M695.29M697.65M828.49M644.36M585.79M541.5M461.21M379.83M327.64M265.54M211.64M156.7M46.65M-36.09M-43.04M
Equity Growth %-1.13%0.11%-3.62%-0.34%-15.79%28.58%10%8.18%17.41%21.43%15.93%23.39%25.47%35.06%235.9%229.26%16.14%-
Book Value per Share28.1327.6726.5826.5125.4529.9623.9621.6619.8517.1814.3012.4510.178.186.413.53-1.81-2.16
Total Shareholders' Equity683.13M670.87M670.15M695.29M697.65M828.49M644.36M585.79M541.5M461.21M379.83M327.64M265.54M211.64M156.7M46.65M-36.09M-43.04M
Common Stock24K024K26K27K28K27K27K27K27K26K26K26K26K25K19K1K1K
Retained Earnings248.88M0244.41M256.4M258.24M376.73M362.9M324.72M291.46M224.7M176.7M134M87.48M45.85M10.57M-27.74M-41.54M-48.31M
Treasury Stock000000000000000000
Accumulated OCI-23.49M0-27.98M-28.01M-34.35M-16.82M-3.42M-7.02M-8.49M-5.23M-10.75M-5.21M-2.93M-1.09M-928K-738K-458K-244K
Minority Interest000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Goodwill impairment and competition

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Robust Liquidity Supports Operational Flexibility

As reported in recent financial filings, Proto Labs maintains a strong liquidity position with cash reserves reaching $124.0 million in 2026Q1, while consistently sustaining a current ratio above 3.0, which provides a substantial buffer against cyclical downturns in industrial R&D spending and potential supply chain volatility.

The company's ability to maintain a current ratio of 3.51 suggests a conservative approach to working capital management that prioritizes immediate solvency. This liquidity profile provides management with significant optionality to navigate periods of reduced demand without the need for external financing.

Asset Composition Reflects Strategic Pivot

Based on the provided balance sheet data, Proto Labs carries $274.0 million in goodwill, representing a significant portion of its $778.6 million total assets, which warrants close investor monitoring given the potential for future impairment if the Protolabs Network integration fails to meet long-term growth expectations.

The concentration of goodwill relative to net PPE of $212.3 million highlights the company's transition from a purely asset-heavy manufacturing model to a hybrid platform. Investors should consider whether the carrying value of these intangible assets remains supported by the underlying cash flows of the acquired network business.

Minimal Leverage Preserves Financial Optionality

According to the latest quarterly balance sheet, Proto Labs operates with a negligible debt-to-equity ratio of 0.00, effectively maintaining a debt-free capital structure that insulates the firm from interest rate sensitivity and provides a distinct competitive advantage compared to more highly leveraged industrial peers in the manufacturing sector.

The near-zero debt profile suggests a management philosophy that favors financial independence over aggressive capital structure optimization. This lack of leverage is particularly valuable in the current environment, as it allows the company to self-fund R&D and potential M&A without the burden of mandatory debt service.

Equity Quality Impacted by Dilution

As indicated by historical financial statements, the company's equity base of $683.1 million is supported by retained earnings, yet investors should monitor the ongoing impact of stock-based compensation, which may continue to exert downward pressure on per-share value despite the firm's overall strong balance sheet position.

While the equity base remains stable, the persistent use of equity-based incentives to attract software talent creates a structural drag on shareholder returns. Analysts should evaluate whether the growth generated by these hires sufficiently offsets the dilution occurring at the equity level.

PRLB — Frequently Asked Questions

Quick answers to the most common questions about buying PRLB stock.

What are the total assets of Proto Labs, Inc. (PRLB)?

As of 2025, Proto Labs, Inc. (PRLB) had total assets of $760.4M including $233.5M in current assets.

How much debt does Proto Labs, Inc. (PRLB) have?

Proto Labs, Inc. (PRLB) carries total debt of $4.7M, offset by $128.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Proto Labs, Inc.?

Proto Labs, Inc. (PRLB) has total shareholders' equity (book value) of $670.9M ($27.67 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Proto Labs, Inc.'s current ratio and liquidity?

Proto Labs, Inc. (PRLB) reported a current ratio of 3.49x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.